For the year ending 2025-12-31, MGNX made $149,500K in revenue. -$74,592K in net income. Net profit margin of -49.89%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 149,500 | |||
| Cost of product sales | 0 | |||
| Cost of manufacturing services | 36,009 | |||
| Research and development | 147,172 | |||
| Selling, general and administrative | 39,160 | |||
| Total costs and expenses | 222,341 | |||
| Loss from operations | -72,841 | |||
| Gain on royalty monetization arrangement | 0 | |||
| Gain on sale of margenza | 0 | |||
| Interest and other income | 6,057 | |||
| Interest and other expense | 8,508 | |||
| Loss before income taxes | -75,292 | |||
| Income tax (benefit) expense | -672 | |||
| Net loss | -74,620 | |||
| Unrealized gain (loss) on investments | 28 | |||
| Comprehensive loss | -74,592 | |||
| Basic EPS | -1.18 | |||
| Diluted EPS | -1.18 | |||
| Basic Average Shares | 63,155,096 | |||
| Diluted Average Shares | 63,155,096 | |||
MACROGENICS INC (MGNX)
MACROGENICS INC (MGNX)